23 A Toolkit for Health Care Professionals Screening for Kidney Disease to Reduce CVD Risk 14. Shlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Ix, J. H., Jha, V., Kengne, A. P., Madero, M., Mihaylova, B., Tangri, N., Cheung, M., Jadoul, M., Winkelmayer, W. C., Zoungas, S., & Conference Participants (2021). The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international, 99(1), 34–47. https://doi.org/10.1016/j.kint.2020.10.012 15. de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, Rosas SE, Rossing P, Bakris G. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022 Dec 1;45(12):3075-3090. doi: 10.2337/ dci22-0027. PMID: 36189689; PMCID: PMC9870667. 16. American Diabetes Association Professional Practice Committee. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 2024 Jan 1;47(Suppl 1):S219-S230. doi: 10.2337/ dc24-S011. PMID: 38078574; PMCID: PMC10725805. 17. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022 Nov;102(5S):S1-S127. doi: 10.1016/j. kint.2022.06.008. PMID: 36272764. 18. Grams ME, Brunskill NJ, Ballew SH, et al. Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes. Diabetes Care. Sep 1 2022;45(9):2055-2063. doi:10.2337/dc220698 19. Naaman SC, Bakris GL. Diabetic Nephropathy: Update of Pillars of Therapy Slowing Progression. Diabetes Care 2023;46(9):1574–1586 | https://doi. org/10.2337/dci23-0030 20. Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A; World Kidney Day Joint Steering Committee. Mind the gap in kidney care: translating what we know into what we do. Kidney Int. 2024 Mar;105(3):406-417. doi: 10.1016/j. kint.2023.12.003. PMID: 38375622. 21. Neuen BL, Tuttle KR, Vaduganathan M. Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease. Circulation. 2024 Apr 16;149(16):1238-1240. doi: 10.1161/ CIRCULATIONAHA.123.068524. Epub 2024 Apr 15. PMID: 3862008 22. Neumiller JJ, Alicic RZ, Tuttle KR. Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease. Clin Kidney J. 2023 Nov 16;17(1):sfad285. doi: 10.1093/ckj/sfad285. PMID: 38213492; PMCID: PMC10783256. 23. Limonte CP, Lamprea-Montealegre JA, Tuttle KR. Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease. Semin Nephrol. 2024 May 4:151520. doi: 10.1016/j. semnephrol.2024.151520. Epub ahead of print. PMID: 38705774. 24. Zacharias HU, Altenbuchinger M, Schultheiss UT, et al. A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests. Am J Kidney Dis. Feb 2022;79(2):217-230.e1. doi:10.1053/j.ajkd.2021.05.018 25. Lam D, Nadkarni GN, Mosoyan G, et al. Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial. Am J Nephrol. 2022;53(1):21-31. doi:10.1159/000519920 26. Tangri N, Grams ME, Levey AS, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. Jama. Jan 12 2016;315(2):164-74. doi:10.1001/ jama.2015.18202 27. Nelson RG, Grams ME, Ballew SH, et al. Development of Risk Prediction Equations for Incident Chronic Kidney Disease. Jama. Dec 3 2019;322(21):21042114. doi:10.1001/jama.2019.17379 28. Centers for Disease Control and Prevention. https://www.cdc.gov/kidneydisease/media/pdfs/CKD-Factsheet-H. pdf. 29. Edward P. Havranek, MD, FAHA, Mahasin S. Mujahid, PhD, MS, et al. Social Determinants of Risk and Outcomes for Cardiovascular Disease. Circulation. Aug. 3, 2015. https://doi.org/10.1161/ CIR.0000000000000228
RkJQdWJsaXNoZXIy MjI2NjI=